Study of the Bioavailability of Three Hesperidin Extracts.
Condition(s):Biological AvailabilityLast Updated:February 28, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Biological AvailabilityLast Updated:February 28, 2022Completed
Condition(s):Covid19; Anosmia; Fever; Cough; Shortness of Breath; Sore Throat; Nausea; Vomiting; Headache; Muscle Weakness; Pain, Muscle; Pain, Chest; Pain, Joint; Pain, Abdominal; Pain; Irritable Mood; ConfusionLast Updated:April 8, 2022Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:May 17, 2018Completed
Condition(s):Higher Uric Acid Concentrations (>5,5 mg/dl); HealthyLast Updated:July 3, 2023Completed
Condition(s):BioequivalenceLast Updated:February 14, 2022Completed
Condition(s):Obesity; Insulin ResistanceLast Updated:March 4, 2022Withdrawn
Condition(s):Endothelial Dysfunction; Metabolic SyndromeLast Updated:June 17, 2009Unknown status
Condition(s):Vinca Alkaloid Adverse ReactionLast Updated:February 17, 2022Not yet recruiting
Condition(s):Venous InsufficiencyLast Updated:June 20, 2018Completed
Condition(s):Power; Metabolic Disturbance; Change, Body Weight; Changes Fatty; Muscle Loss; Oxidative Stress; Inflammatory Response; Oxygen Deficiency; Acid-Base Imbalance; Electrolyte DisturbanceLast Updated:October 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.